U.S. drug regulator OKs 2nd coronavirus vaccine, from Moderna

The U.S. drug regulator on Friday granted an emergency use authorization for Moderna Inc.'s coronavirus vaccine, setting the stage for the rollout of the second vaccine to fight the pandemic in the United States.The vaccine, which requires two doses administered one month apart, will be distributed for use in individuals 18 years of age or older. It was confirmed through a clinical trial to be 94.1 percent effective in preventing COVID-19, the illness caused by the virus, according to the Food and Drug Administration.The U.S. biotechnology company filed its application with the FDA on Nov. …READ FULL ARTICLE